In view of the new and mostly well-tolerated therapies, the palliative life and treatment time of oncological patients is increasingly extended. It is a major challenge to identify patients in need of palliative support in an accurate and needs-based manner, as recommended in guidelines. In the context of Germany and Switzerland, a distinction is made between general palliative care (APV) and specialized palliative care (SPV).
Autoren
- Prof. Dr. med. Birgitt van Oorschot
- Dr. med. Carmen Roch
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Arterial hypertension: ESC guideline 2024 in focus
New category “elevated blood pressure” – what are the therapeutic implications?
- Low-grade pediatric gliomas
Consideration of the tumor microenvironment opens up new treatment options
- Palliative care symptom and needs assessment.
What screening tools are helpful?
- Patient-centered rounds in medicine
Aligning care with the patient
- HIV: antiretroviral therapy (ART)
Single-tablet regimens support adherence
- Rare pulmonary syndromes
Yellow nail and Swyer-James syndrome
- Vaccinations against viral respiratory infections
Influenza, Covid-19 and RSV – Update 2025
- GLP1-RA therapy